A Phase I/II Study of Autologous Stem Cell Transplantation Followed by Non-Myeloablative Allogeneic Stem Cell Transplantation for Patients With Relapsed or Refractory Lymphoma - A Multi Center Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmustine; Ciclosporin; Cyclophosphamide; Cytarabine; Etoposide; Fludarabine; Melphalan; Mycophenolate mofetil
- Indications B-cell prolymphocytic leukaemia; Chronic lymphocytic leukaemia; Graft-versus-host disease; Hodgkin's disease; Lymphoma; Non-Hodgkin's lymphoma; T-cell prolymphocytic leukaemia
- Focus Therapeutic Use
- 29 Jan 2020 Biomarkers information updated
- 21 Sep 2010 Planned end date changed from 1 Sep 2010 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 29 Nov 2005 New trial record.